//
home

Latest Post

Imbruvica Continues to Shine

The medication Imbruvica® (ibrutinib) from AbbVie offers well-researched benefits for several blood cancers. Last month, my blog Potential New Medication for Lymphoma, shared how this medication was approved by the FDA in 2013 for mantle cell lymphoma, with approvals for chronic lymphocytic leukemia and Waldenstrom’s macroglobulinemia coming in the following years. Now Imbruvica is undergoing … Continue reading

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 167 other followers

Twitter Updates

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 167 other followers

Like Us On Facebook!

March 2017
M T W T F S S
« Feb    
 12345
6789101112
13141516171819
20212223242526
2728293031  

Archives